Pediatr. praxi. 2025;26(4):222-225 | DOI: 10.36290/ped.2025.043

Allergic rhinitis in children

MUDr. Barbora Koubková
Oddělení alergologie a klinické imunologie FN Olomouc

Allergic rhinitis is the most common non-infectious rhinitis with a prevalence od 10-20% of the population in the developed countries. In the pediatric population it mainly concerns children older than 5 years, but in recent years the first symptoms appear already in toddler- and preschool-age. Inadequate therapy of allergic rhinitis can lead to the progression of asthma and skin atopic manifestations in pediatric patients. These aspects, together with the decrease of the child's quality of life, are the main reasons for consistent diagnosis and therapy of allergic rhinitis based on the recommendations of the ARIA 2019 iniciative.

Keywords: allergic rhinitis in children, diagnostics and therapy, ARIA 2019 recommendations.

Accepted: August 20, 2025; Published: September 26, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koubková B. Allergic rhinitis in children. Pediatr. praxi. 2025;26(4):222-225. doi: 10.36290/ped.2025.043.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 40 CZK

    References

    1. . Petrů V a kol. Dětská alergologie, 2., přepracované a doplněné vydání. Maxdorf. 2021.
    2. . Studie zdravotního stavu obyvatelstva - alergie [Internet]. Státní zdravotní ústav; [cited 2025-08-15]. Available from: https://szu.gov.cz/temata-zdravi-a-bezpecnosti/studie-zdravotniho-stavu-obyvatelstva/deti/alergie/.
    3. . Seberová E. Alergická rýma. Doporučení ČSAKI [Internet]. ČSAKI. [cited 2025-08-15]. Available from: http://www.csaki.cz/alergicka-ryma.
    4. . Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guideline for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2019;143(3):879-893.
    5. . Dymistin nas. spr., Ryaltris nas. spr. SPC. Souhrn údajů o přípravku. Databáze léků [Internet]. SÚKL. [cited 2025-08-15]. Available from: http://www.sukl.cz.
    6. . Allergocrom nas. spr. SPC. Souhrn údajů o přípravku. Databáze léků [Internet]. SÚKL. [cited 2025-08-15]. Available from: http://www.sukl.cz.
    7. . Souhrn údajů o přípravku. Clarinase Repetabs. SPC. Databáze léků [Internet]. SÚKL. [cited 2025-08-15]. Available from: http://www.sukl.cz.
    8. . Yang J, Lei S. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis. Front Immunol. 2023;14:1119315. Go to original source... Go to PubMed...
    9. . Rhyou HI, Nam YH. Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice. Allergy Asthma Immunol Res. 2020;12(2):282-297. Go to original source... Go to PubMed...
    10. . Contoli M, Porsbjerg C, et al. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study. J Allergy Clin Immunol. 2023;151(3):824-835.e10. Go to original source... Go to PubMed...
    11. . Phostal injekční suspenze, Pollinex Rye/Tree injekční suspenze. SPC. Souhrn údajů o přípravku. Databáze léků [Internet]. SÚKL. [cited 2025-08-15]. Available from: http://www.sukl.cz.
    12. . Staloral sublingvální roztok. SPC. Souhrn údajů o přípravku. Databáze léků [Internet]. SÚKL. [cited 2025-08-15]. Available from: http://www.sukl.cz.
    13. . Acarizax sublingvální lyofilizát. SPC. Souhrn údajů o přípravku. Databáze léků [Internet]. SÚKL. [cited 2025-08-15]. Available from: http://www.sukl.cz.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.